Related Experiment Videos

An attempt to quantify magnetic resonance imaging in multiple sclerosis--correlation with clinical parameters

L Kappos1, D Städt, W Keil

  • 1Max Planck-Gesellschaft, Clinical Research Unit for Multiple Sclerosis, Würzburg, West Germany.

Neurosurgical Review
|January 1, 1987
PubMed

Insights

Magnetic resonance imaging (MRI) can quantify multiple sclerosis (MS) lesion volume. This planimetric MRI method aids in monitoring disease activity and may assist in evaluating treatments for central nervous system diseases.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Magnetic resonance imaging (MRI) is crucial for diagnosing multiple sclerosis (MS).
  • Limited data exists on MRI's utility in monitoring MS disease activity over time.
  • Quantitative MRI methods are needed for objective disease assessment.

Purpose of the Study:

  • To describe and evaluate a quantitative method for assessing demyelinating lesion volume in MS using MRI.
  • To correlate lesion volume with clinical disability scores in MS patients.

Main Methods:

  • A standardized MRI scanning protocol was employed.
  • An interactive planimetric computer system quantified lesion area.
  • Lesion volume was calculated by multiplying area by slice thickness.

Main Results:

  • Eighty-nine patients with clinically definite MS were analyzed.
  • Average lesion volume was 11900 mm3, with a mean Kurtzke expanded disability scale score of 3.0.
  • A weak but significant correlation (rho = 0.3) was found between lesion volume and neurological deficit.

Conclusions:

  • Planimetric MRI evaluation is a valuable supplement to clinical rating scales for MS.
  • This quantitative method, combined with advanced MRI technology, shows promise for evaluating treatments in various central nervous system diseases.

Related Concept Videos